Page last updated: 2024-11-07

carbachol and Dermatitis, Atopic

carbachol has been researched along with Dermatitis, Atopic in 2 studies

Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.

Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kanwar, AJ1
Pasricha, JS1
Malaviya, AM1
Butler, JM1
Ebertz, M1
Chan, SC1
Stevens, SR1
Sobieszczuk, D1
Hanifin, JM1

Other Studies

2 other studies available for carbachol and Dermatitis, Atopic

ArticleYear
Reassessment of the significance of delayed blanch phenomenon and serum tigE levels in atopic disorders.
    Annals of allergy, 1977, Volume: 38, Issue:4

    Topics: Asthma; Carbachol; Dermatitis, Atopic; Humans; Hypersensitivity, Immediate; Immunoglobulin E; Intrad

1977
Basophil histamine release in atopic dermatitis and its relationship to disordered cyclic nucleotide metabolism.
    Acta dermato-venereologica. Supplementum, 1985, Volume: 114

    Topics: 3',5'-Cyclic-AMP Phosphodiesterases; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Basophils; Carb

1985